Cite

HARVARD Citation

    Mirvis, E. et al. (2020). Efficacy and tolerability of peptide receptor radionuclide therapy (PRRT) in advanced metastatic bronchial neuroendocrine tumours (NETs). Lung cancer. pp. 70-75. [Online]. 
  
Back to record